HBM HOLDINGS-B (02142) Reports 2025 Financial Results with USD 92.22 Million After-Tax Profit, Surging Approximately 32.63-Fold

Stock News03-30

HBM HOLDINGS-B (02142) announced its 2025 financial results, revealing revenue of approximately USD 158 million, a year-on-year increase of 314.63%. The annual profit reached USD 92.22 million, representing a surge of about 32.63 times compared to the previous year. The basic earnings per share stood at USD 0.12. Throughout 2025, the company fully advanced into its 3.0 strategic phase, driven by three core growth engines: establishing Nona Biosciences as an AI-powered global "new infrastructure" for antibody drug discovery; forging long-term, platform-based strategic partnerships with multinational pharmaceutical companies to accelerate global expansion; and maximizing the global value of mid-to-late-stage assets in areas such as autoimmunity and oncology through Harbour Therapeutics.

Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.

Comments

We need your insight to fill this gap

Leave a comment

{"i18n":{"language":"en_US"},"isChannel":false,"data":{"share":"https://ttm.financial/m/news/1106729001?lang=en_US&edition=fundamental","thumbnail":"","is_english":true,"pubTime":"2026-03-30 22:52","share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","id":"1106729001","market":"us","top_or_hot":-1,"title":"HBM HOLDINGS-B (02142) Reports 2025 Financial Results with USD 92.22 Million After-Tax Profit, Surging Approximately 32.63-Fold","media":"Stock News","content":"<p>HBM HOLDINGS-B (02142) announced its 2025 financial results, revealing revenue of approximately USD 158 million, a year-on-year increase of 314.63%. The annual profit reached USD 92.22 million, representing a surge of about 32.63 times compared to the previous year. The basic earnings per share stood at USD 0.12. Throughout 2025, the company fully advanced into its 3.0 strategic phase, driven by three core growth engines: establishing Nona Biosciences as an AI-powered global \"new infrastructure\" for antibody drug discovery; forging long-term, platform-based strategic partnerships with multinational pharmaceutical companies to accelerate global expansion; and maximizing the global value of mid-to-late-stage assets in areas such as autoimmunity and oncology through Harbour Therapeutics.</p>","source":null,"html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>HBM HOLDINGS-B (02142) Reports 2025 Financial Results with USD 92.22 Million After-Tax Profit, Surging Approximately 32.63-Fold</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nHBM HOLDINGS-B (02142) Reports 2025 Financial Results with USD 92.22 Million After-Tax Profit, Surging Approximately 32.63-Fold\n</h2>\n\n<h4 class=\"meta\">\n\n\n<a class=\"head\" href=\"https://laohu8.com/wemedia/1036600163\">\n\n\n<div class=\"h-thumb\" style=\"background-image:url(https://community-static.tradeup.com/news/b3bf6d02ad1a6e9e7377eebbb162346a);background-size:cover;\"></div>\n\n<div class=\"h-content\">\n<p class=\"h-name\">Stock News </p>\n<p class=\"h-time\">2026-03-30 22:52</p>\n</div>\n\n</a>\n\n\n</h4>\n\n</header>\n<article>\n<p>HBM HOLDINGS-B (02142) announced its 2025 financial results, revealing revenue of approximately USD 158 million, a year-on-year increase of 314.63%. The annual profit reached USD 92.22 million, representing a surge of about 32.63 times compared to the previous year. The basic earnings per share stood at USD 0.12. Throughout 2025, the company fully advanced into its 3.0 strategic phase, driven by three core growth engines: establishing Nona Biosciences as an AI-powered global \"new infrastructure\" for antibody drug discovery; forging long-term, platform-based strategic partnerships with multinational pharmaceutical companies to accelerate global expansion; and maximizing the global value of mid-to-late-stage assets in areas such as autoimmunity and oncology through Harbour Therapeutics.</p>\n\n</article>\n</div>\n</body>\n</html>\n","isBrief":false,"type":0,"news_type":1,"symbol":"BK1574","symbol_name":"生物医药B类股","start_time":0,"source_url":"","article_id":"1106729001","we_media_id":"1036600163","thumbnails":[],"rights":null,"url":"https://stock-news.laohu8.com/highlight/detail?id=1106729001","pubTimestamp":1774882347,"columns":[],"sourceInfo":null,"weMediaInfo":{"media_name":"Stock News","introduction":"Global Stock News First-Time Broadcast","home_visible":1,"id":"1036600163","head_image":"https://community-static.tradeup.com/news/b3bf6d02ad1a6e9e7377eebbb162346a"},"summary":"HBM HOLDINGS-B (02142) announced its 2025 financial results, revealing revenue of approximately USD 158 million, a year-on-year increase of 314.63%. The annual profit reached USD 92.22 million,...","collect":0,"end_time":0,"defaultTopTitle":"","property":[],"viewcount":null,"language":"en","relate_stocks":{"BK1574":"生物医药B类股","BK1583":"高瓴概念","BK1161":"生物科技","02142":"和铂医药-B"},"translate_title":"HBM HOLDINGS-B(02142)公布2025年财报税后利润9222万美元暴涨约32.63倍","themeId":"","isJumpTheme":false,"ttsUrl":null,"symbols_score_info":{"02142":1},"content_text":"HBM HOLDINGS-B (02142) announced its 2025 financial results, revealing revenue of approximately USD 158 million, a year-on-year increase of 314.63%. The annual profit reached USD 92.22 million, representing a surge of about 32.63 times compared to the previous year. The basic earnings per share stood at USD 0.12. Throughout 2025, the company fully advanced into its 3.0 strategic phase, driven by three core growth engines: establishing Nona Biosciences as an AI-powered global \"new infrastructure\" for antibody drug discovery; forging long-term, platform-based strategic partnerships with multinational pharmaceutical companies to accelerate global expansion; and maximizing the global value of mid-to-late-stage assets in areas such as autoimmunity and oncology through Harbour Therapeutics.","kind":"news","is_publish_news":true,"is_publish_highlight":false,"is_publish_live":false,"is_publish_wemedia":null,"editions":null,"column":"","sentiment":"2","news_tag":"","news_rank":0,"isVideo":false,"video":null,"symbols":[],"gpt_button":1,"need_auth":false,"need_login_tip":false,"code":"91000000","status":"200"},"commentList":[],"isCommentEnd":true,"newsSizeData":{"likeSize":0,"commentSize":0,"repostSize":0,"favoriteSize":0,"likeStatus":false,"favoriteStatus":false},"APP":{"userAgent":"Mozilla/5.0 AppleWebKit/537.36 (KHTML, like Gecko; compatible; ClaudeBot/1.0; +claudebot@anthropic.com)","isDev":false,"isTTM":true,"tenantId":"TBGLOBAL","deviceId":"web-server-community-laohu8-v3","version":"4.42.0","shortVersion":"4.42.0","platform":"web","vendor":"web","appName":"ttm","isIOS":false,"isAndroid":false,"isTiger":false,"isTHS":false,"isWeiXin":false,"isWeiXinMini":false,"isWeiBo":false,"isQQ":false,"isBaiduSwan":false,"isBaiduBox":false,"isDingTalk":false,"isToutiao":false,"isOnePlus":false,"isHuaWei":false,"isXiaomi":false,"isXiaomiWebView":false,"isOppo":false,"isVivo":false,"isSamsung":false,"isMobile":false},"href":"/m/news/1106729001","isCrawlerRequest":true}